Cumulus Oncology has secured a £4.1m investment led by St Andrews-based investment firm Eos Advisory.
Scottish Enterprise invested alongside Eos, as the biotech company plans further scale, with an additional £1.5m due to follow in the coming months.
Cumulus was founded in 2017 to identify novel oncology assets to de-risk and add value to, before creating spin-out companies to commercialise novel cancer therapies.
